Literature DB >> 20978628

Intratympanic steroids in severe to profound sudden sensorineural hearing loss as salvage treatment.

Jong Dae Lee1, Moo Kyun Park, Chi-Kyou Lee, Kye Hoon Park, Byung Don Lee.   

Abstract

OBJECTIVES: Intratympanic steroids are being increasingly used in the treatment of sudden sensorineural hearing loss (SSNHL) after the failure of systemic therapy. This study evaluated the efficacy of administering intratympanic dexamethasone (ITD) as a salvage treatment for severe to profound SSNHL.
METHODS: We reviewed the medical records of patients who presented with severe to profound SSNHL between January 2007 and December 2009. ITD was given about 14 days after the initial systemic treatment. Successful recovery was defined as complete or partial recovery using Sigel's criteria. We compared the results of treatment between the severe SSNHL (S-SSNHL) and profound SSNHL (P-SSNHL) groups.
RESULTS: All the patients in the S-SSNHL group showed significant improvement, as compared to the P-SSNHL group (P=0.017). The recovery rate after the initial systemic treatment was 36% (9/25) in the S-SSNHL group and 18.1% (4/22) in the P-SSNHL group (P=0.207). In comparison, the recovery rate of ITD as a salvage treatment was 37.5% (6/16) in the S-SSNHL group and 5.5% (1/18) in the P-SSNHL group (P=0.03).
CONCLUSION: Our comparative study dose not support the efficacy of ITD as salvage treatment for patients with P-SSNHL as compared with that for S-SSNHL. We recommend that patients with P-SSNHL be informed about the low efficacy of ITD as a salvage treatment.

Entities:  

Keywords:  Intratympanic; Steroid; Sudden sensorineural hearing loss

Year:  2010        PMID: 20978628      PMCID: PMC2958501          DOI: 10.3342/ceo.2010.3.3.122

Source DB:  PubMed          Journal:  Clin Exp Otorhinolaryngol        ISSN: 1976-8710            Impact factor:   3.372


  15 in total

Review 1.  Idiopathic sudden sensorineural hearing loss.

Authors:  D E Mattox; C A Lyles
Journal:  Am J Otol       Date:  1989-05

Review 2.  Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.

Authors:  David S Haynes; Matthew O'Malley; Seth Cohen; Kenneth Watford; Robert F Labadie
Journal:  Laryngoscope       Date:  2007-01       Impact factor: 3.325

3.  How long should the sudden hearing loss patients be followed after early steroid combination therapy?

Authors:  In Seok Moon; Jin Kim; So-Yoon Lee; Hyun Seung Choi; Won-Sang Lee
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-03-13       Impact factor: 2.503

4.  Dexamethasone pharmacokinetics in the inner ear: comparison of route of administration and use of facilitating agents.

Authors:  S S Chandrasekhar; R Y Rubinstein; J A Kwartler; M Gatz; P E Connelly; E Huang; S Baredes
Journal:  Otolaryngol Head Neck Surg       Date:  2000-04       Impact factor: 3.497

5.  Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application.

Authors:  L S Parnes; A H Sun; D J Freeman
Journal:  Laryngoscope       Date:  1999-07       Impact factor: 3.325

6.  Hearing outcomes of daily intratympanic dexamethasone alone as a primary treatment modality for ISSHL.

Authors:  Seok Min Hong; Chan Hum Park; Jun Ho Lee
Journal:  Otolaryngol Head Neck Surg       Date:  2009-11       Impact factor: 3.497

7.  Modified intratympanic treatment for idiopathic sudden sensorineural hearing loss.

Authors:  Emrah Kara; Fikret Cetik; Ozgür Tarkan; Ozgür Sürmelioğlu
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-10-28       Impact factor: 2.503

8.  Clinical efficacy of initial intratympanic steroid treatment on sudden sensorineural hearing loss with diabetes.

Authors:  Chi-Sung Han; Jong-Ryul Park; Sung-Hyun Boo; Joon-Man Jo; Kyung-Won Park; Won-Yong Lee; Joong-Gi Ahn; Myung-Koo Kang; Byung-Gun Park; Hyun Lee
Journal:  Otolaryngol Head Neck Surg       Date:  2009-10-01       Impact factor: 3.497

9.  Effectiveness of intratympanic dexamethasone injection in sudden-deafness patients as salvage treatment.

Authors:  Ho Guan-Min Ho; Hung-Ching Lin; Min-Tsan Shu; Cheng-Chien Yang; Hsun-Tien Tsai
Journal:  Laryngoscope       Date:  2004-07       Impact factor: 3.325

10.  Combination therapy (intratympanic dexamethasone + high-dose prednisone taper) for the treatment of idiopathic sudden sensorineural hearing loss.

Authors:  Alex Battaglia; Raoul Burchette; Roberto Cueva
Journal:  Otol Neurotol       Date:  2008-06       Impact factor: 2.311

View more
  7 in total

1.  Intratympanic dexamethasone perfusion versus injection for treatment of refractory sudden sensorineural hearing loss.

Authors:  Lihua Li; Jihao Ren; Tuanfang Yin; Wei Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-06-06       Impact factor: 2.503

2.  Hearing Changes After Intratympanically Applied Steroids for Primary Therapy of Sudden Hearing Loss: A Meta-analysis Using Mathematical Simulations of Drug Delivery Protocols.

Authors:  Arne Liebau; Olivia Pogorzelski; Alec N Salt; Stefan K Plontke
Journal:  Otol Neurotol       Date:  2017-01       Impact factor: 2.311

Review 3.  Are intra-tympanically administered steroids effective in patients with sudden deafness? Implications for current clinical practice.

Authors:  Petros V Vlastarakos; George Papacharalampous; Paul Maragoudakis; George Kampessis; Nicholas Maroudias; Dimitrios Candiloros; Thomas P Nikolopoulos
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-08-19       Impact factor: 2.503

4.  Comparison of two different steroid treatments with hyperbaric oxygen for idiopathic sudden sensorineural hearing loss.

Authors:  Ergun Sevil; Sami Bercin; Togay Muderris; Fatih Gul; Muzaffer Kiris
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-11-04       Impact factor: 2.503

5.  A randomized controlled clinical trial of topical insulin-like growth factor-1 therapy for sudden deafness refractory to systemic corticosteroid treatment.

Authors:  Takayuki Nakagawa; Kozo Kumakawa; Shin-ichi Usami; Naohito Hato; Keiji Tabuchi; Mariko Takahashi; Keizo Fujiwara; Akira Sasaki; Shizuo Komune; Tatsunori Sakamoto; Harukazu Hiraumi; Norio Yamamoto; Shiro Tanaka; Harue Tada; Michio Yamamoto; Atsushi Yonezawa; Toshiko Ito-Ihara; Takafumi Ikeda; Akira Shimizu; Yasuhiko Tabata; Juichi Ito
Journal:  BMC Med       Date:  2014-11-19       Impact factor: 8.775

6.  Impact of control of blood glucose level during treatment of sudden deafness in diabetics: relationship with prognosis.

Authors:  Sang-Ki Min; Ji-Ho Shin; Mun-Young Chang; Hyun-Jin Min; Kyung-Soo Kim; Sei-Young Lee; Hoon-Shik Yang; Young-Ho Hong; Seog-Kyun Mun
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-11-16       Impact factor: 2.503

7.  The effect of intratympanic dexamethasone with oral prednisolone as a primary treatment in idiopathic sudden sensorineural hearing loss.

Authors:  Mohammad Taghi Khorsandi Ashtiani; Pedram Borgheie; Nasrin Yazdani; Shirin Maghsoud
Journal:  Iran J Otorhinolaryngol       Date:  2012
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.